Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy [ID6369] Draft guidance Technology appraisal guidance 2 April ...
With the Open To Work feature, you can privately tell recruiters or publicly share with the LinkedIn community that you are looking for new job opportunities. Sending messages to people you know ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback